市场调查报告书
商品编码
1562238
中东和非洲近视治疗市场预测至 2030 年 - 区域分析 - 按类型、治疗、年龄层和最终用户Middle East & Africa Myopia Treatment Market Forecast to 2030 - Regional Analysis - by Type, Treatment, Age Group, and End User |
2022年中东和非洲近视治疗市场价值为2.633亿美元,预计到2030年将达到4.6581亿美元;预计2022年至2030年复合年增长率为7.4%。
人工智慧在近视治疗的应用提振中东和非洲近视治疗市场
人工智慧(AI)越来越多地应用于近视治疗。一个例子是使用人工智慧设备来监测和分析眼球运动和视力,这可以帮助识别近视的早期迹象并追踪其进展。人工智慧演算法还可用于根据患者的特征和病史制定个人化的治疗计划。未来,人工智慧有望在近视治疗中发挥更大作用。例如,研究人员正在探索使用机器学习演算法来预测近视高风险儿童,从而进行早期介入和预防。
此外,人工智慧驱动的虚拟实境系统可以提高视力并减少近视加深。因此,近视治疗市场预计在未来几年将持续成长和创新。随着全球近视盛行率的不断上升,对有效且易于使用的治疗方法的需求日益增长。人工智慧和先进手术技术等技术进步预计将推动这一成长,并带来更个人化和有效的近视治疗。此外,人们可能会更加关注预防措施以及工业界和学术界之间的合作,以解决这个全球健康问题。
中东和非洲近视治疗市场概况
中东和北非由三个主要国家组成:阿拉伯联合大公国(阿联酋)、沙乌地阿拉伯和南非。阿联酋是最大的近视治疗市场。该市场的驱动因素包括眼部疾病发病率的增加、消费者近视意识的增强以及国际企业在该地区渗透率的提高。
沙乌地阿拉伯在改善眼睛健康方面取得了长足进步。根据世界卫生组织的数据,沙乌地阿拉伯约有 8,000 名儿童患有功能性低视力。先天性青光眼是该国儿童失明的主要原因之一。此外,在预测期内,电脑和智慧型手机的使用不断增加,创造了对眼部补充剂的需求。预防失明和耳聋已被纳入沙乌地阿拉伯新的初级卫生保健政策。为了保持眼部保健的连续性,现有卫生机构正在製定一项为期 5-10 年的计划,其中包括早产儿视网膜病变 (ROP)、学龄前视力、糖尿病视网膜病变、青光眼和白内障的筛检。卫生部正在全国另外设立四个眼科中心来提供这些服务。因此,该国政府正在实施运动和社区教育计划,这是眼睛健康促进策略的影响因素。这些策略有助于提高意识并鼓励社区承担起眼睛健康的责任。该行动进一步加强了现有眼部保健服务的适当利用。例如,卫生部 (MoH) 提供有关眼部疾病的教育资讯。这有助于教育人们有关青光眼、近视、弱视、糖尿病视网膜病变和隐形眼镜的知识。因此,上述因素预计将为未来几年近视治疗市场的成长提供有利可图的机会。
中东和非洲近视治疗市场收入及 2030 年预测(百万美元)
中东和非洲近视治疗市场细分
中东和非洲近视治疗市场按类型、治疗、年龄层、最终用户和国家分类。
根据类型,中东和非洲近视治疗市场分为高度近视、退化性近视和进行性近视。 2022 年,高度近视细分市场占据中东和非洲近视治疗市场最大份额。
在治疗方面,中东和非洲近视治疗市场分为低剂量阿托品眼药水、隐形眼镜、角膜塑形镜和屈光手术。到2022年,低剂量阿托品眼药水区隔市场将占据中东和非洲近视治疗市场最大份额。
依年龄组别划分,中东和非洲近视治疗市场分为成人近视和儿童近视。 2022 年,成人近视细分市场在中东和非洲近视治疗市场中占有更大份额。
根据最终用户,中东和非洲近视治疗市场分为医院和诊所、专科诊所和屈光手术中心。 2022 年,医院和诊所细分市场占据中东和非洲近视治疗市场最大份额。
依国家划分,中东和非洲近视治疗市场分为沙乌地阿拉伯、阿联酋、南非以及中东和非洲其他地区。 2022年,沙乌地阿拉伯在中东和非洲近视治疗市场份额中占据主导地位。
Alcon AG、Bausch Health Companies Inc、Carl Zeiss AG、CooperVision Inc、Johnson & Johnson Vision Care Inc 和 Nidek Co Ltd 是中东和非洲近视治疗市场上的一些领先公司。
The Middle East & Africa myopia treatment market was valued at US$ 263.30 million in 2022 and is expected to reach US$ 465.81 million by 2030; it is estimated to register a CAGR of 7.4% from 2022 to 2030.
Application of Artificial Intelligence in Myopia Treatment bolsters Middle East & Africa Myopia Treatment Market
Artificial intelligence (AI) is increasingly being applied in myopia treatment. One example is using AI-powered devices to monitor and analyze eye movements and visual acuity, which can help identify early signs of myopia and track its progression. AI algorithms can also be used to develop personalized patient treatment plans based on their characteristics and medical history. In the future, AI is expected to play an even greater role in myopia treatment. For instance, researchers are exploring the use of machine learning algorithms to predict children who are at high risk of developing myopia, allowing for early intervention and prevention.
Additionally, AI-powered virtual reality systems may improve visual acuity and reduce myopia progression. Thus, the myopia treatment market is expected to see continued growth and innovation in the coming years. With the increasing prevalence of myopia worldwide, there is a growing need for effective and accessible treatments. Advancements in technology, such as AI and advanced surgical techniques, are expected to drive this growth and lead to more personalized and effective treatments for myopia. Additionally, there will likely be a greater focus on preventative measures and collaboration between industry and academia to address this global health concern.
Middle East & Africa Myopia Treatment Market Overview
Middle East & North Africa consists of three major countries: United Arab Emirates (UAE), Saudi Arabia and South Africa. UAE is the largest market for myopia treatment. The market is driven by increasing incidences of eye disorders, growing consumer awareness of myopia, and increasing penetration of international players in the region.
Saudi Arabia has made great strides in improving eye health. As per the WHO, around 8,000 children have functional low vision in Saudi Arabia. Congenital glaucoma is among the leading cause of childhood blindness in the country. Moreover, the increasing use of computers and smartphones creates demand for eye supplements during the forecast period. Prevention of blindness and deafness has been incorporated into Saudi Arabia's new primary health care policy. To maintain a continuum of eye care, a 5-10-year program that encompasses screening for Retinopathy of Prematurity (ROP), preschool vision, diabetic retinopathy, glaucoma, and cataracts is being developed within existing health structures. The MOH is establishing four additional eye centers nationwide to deliver these services. Therefore, the government in the country is implementing campaigns and community-based education programs, which are influential elements for eye health promotion strategies. The strategies help raise awareness and encourage the community to take responsibility for eye health. The action further enforces the appropriate employment of the available eye care services. For instance, the Ministry of Health (MoH) provides educational messages on eye diseases. This helps educate people about glaucoma, myopia, amblyopia, diabetic retinopathy, and contact lenses. Thus, the abovementioned factors are expected to offer lucrative opportunities for the myopia treatment market growth in the coming years.
Middle East & Africa Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Myopia Treatment Market Segmentation
The Middle East & Africa myopia treatment market is categorized into type, treatment, age group, end user, and country.
Based on type, the Middle East & Africa myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest Middle East & Africa myopia treatment market share in 2022.
In terms of treatment, the Middle East & Africa myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest Middle East & Africa myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.
By age group, the Middle East & Africa myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger Middle East & Africa myopia treatment market share in 2022.
Based on end user, the Middle East & Africa myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest Middle East & Africa myopia treatment market share in 2022.
Based on country, the Middle East & Africa myopia treatment market is categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa myopia treatment market share in 2022.
Alcon AG, Bausch Health Companies Inc, Carl Zeiss AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, and Nidek Co Ltd are some of the leading companies operating in the Middle East & Africa myopia treatment market.